[1] |
FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong.
Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184.
|
[2] |
ZHANG Jingsheng, GAO Shuangrong, PANG Bo, LIU Lina, XU Yingli, CAO Shan, CHEN Mengping, ZHANG Yu, ZHAO Ronghua, CUI Xiaolan.
The mechanism of Sanhan Huashi Granules on pneumonia induced by human coronavirus 229E and OC43 in mice
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 51-54.
|
[3] |
ZHANG Jingsheng, JI Zuen, PANG Bo, XU Yingli, CAO Shan, ZHANG Yu, SUN Qiyue, SUN Jing, LI Shuran, ZHANG Wei, ZHAO Ronghua, CUI Xiaolan.
Discussion on traditional Chinese medicine theory and modern pharmacology of Xuanfei Baidu decoction for treating novel coronavirus infection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 55-58.
|
[4] |
LI Shuran, GUO Shanshan, JI Zuen, ZHANG Wei, CUI Xiaolan.
Research status of cognitive dysfunction after SARS-CoV-2 infection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 59-64.
|
[5] |
YUE Lanxin, SHEN Pan, ZHOU Lei, HUANG Congshu, ZHOU Wei, GAO Yue.
The inhibitory effect and mechanism of Celastrol on adipogenic differentiation in 3T3-L1
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 65-73.
|
[6] |
ZHANG Liangliang, HU Changkun, WU Zekun, ZHOU Wei, LIAO Zebin, GAO Yue.
Protective effect and mechanism of dimethyl fumarate against intestinal radiation injury
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 83-88.
|
[7] |
BUCHANAN James.
Assessment of drug-induced liver injury via nR modified Hy’s law and PALT
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 117-120.
|
[8] |
MA Ruize, CHEN Zhihai.
The latest progress of small molecule anti-SARS-CoV-2 drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 961-966.
|
[9] |
HE Huizhen, GUO Yixian, SUN Wanling.
Research progress on targeting CD47 in treatment of lymphoma
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1071-1077.
|
[10] |
MEI Yu, ZHU Yue, ZHANG Huiting, XIAO Chengrong, GAO Yue, MA Zengchun.
Protective mechanism of Chinese medicine compound CB001 against low dose radiation based on network pharmacology and experimental verification
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 872-879.
|
[11] |
HE Xiong, MA Junlong, YANG Guoping.
Adverse events caused by HER2 conjugated antibodies via FAERS
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 915-920.
|
[12] |
YAN Yishu, ZHAO Yan, LU Tiangong, SUN Zhenxiao.
Emodin -8-O-β-D-glucoside combined with paclitaxel inhibits the viability and metastasis of human breast cancer cells
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 728-734.
|
[13] |
LAN Jie, WEN Hairuo, HUANG Zhiying, WANG Qi, MA Shuangcheng.
Cytotoxicity of HK-2 induced by anthraquinones components of Polygonum multiflorum
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 616-622.
|
[14] |
LIU Jingjing, DAI Zhong, YANG Jianbo, WANG Ying, XU Beilei, LIU Yue, WANG Qi, MA Shuangcheng.
Spectrum-fect relationship of Ginseng Radix et Rhizoma Rubra and Polygonum Multiflorum Radix Preparata medicinal pair in protection of nerve cells
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 623-628.
|
[15] |
LIU Jingjing, XU Beilei, YANG Jianbo, WANG Ying, LIU Yue, WANG Qi, MA Shuangcheng.
HT22 Cell and Caenorhabditis elegans models of the anti-aging effect of Ginseng Radix et Rhizoma Rubra and Polygonum Multiflorum Radix preparata medicinal pair
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 629-633.
|